NCT06130800

Brief Summary

Objectives: The objectives of this study are to describe the prevalence of respiratory sarcopenia in institutionalized older adults. Methodology: A sample of approximately 120 older adults from 5 residences located in Murcia capital will participate in the study. A prospective observational study will be carried out, with one year of follow-up, with patients who have been diagnosed with respiratory sarcopenia. Sociodemographic and clinical variables, physical function (palm grip, 5STS, 4MGS), respiratory force variables (MIP and PEF) and diaphragmatic ultrasound (thickness, shortening fraction and diaphragmatic excursion) will be measured. Descriptive statistics, univariate and multivariate logistic regression models, Cox proportional hazards model and KaplanMeier curves will be used to analyze the data from the longitudinal study.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
127

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started May 2023

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2023

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

October 30, 2023

Completed
15 days until next milestone

First Posted

Study publicly available on registry

November 14, 2023

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2023

Completed
1.6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2025

Completed
Last Updated

August 20, 2025

Status Verified

January 1, 2024

Enrollment Period

8 months

First QC Date

October 30, 2023

Last Update Submit

August 15, 2025

Conditions

Keywords

sarcopeniarespiratory forceinstitutionalized elderly

Outcome Measures

Primary Outcomes (8)

  • Sociodemographic

    Sociodemographic dates

    8 MONTHS

  • Clinical variables

    Clinical variables will be extracted from history clinic

    8 MONTHS

  • Palm grip strength

    Palm grip strength will be measured with the digital hand dynamometer (Jamar©). The Participants will remain seated with the shoulder in 0° adduction; elbow flexed 90° and forearm in neutral position. Three attempts will be made and the best value will be chosen

    8 MONTHS

  • 5 SIT TO STAND

    The 5STS test measures the time (in seconds) it takes a subject to stop 5 times from a sitting position, as quickly as possible.

    8 MONTHS

  • 4 METRES

    The gait speed test (4MGS) measures the time it takes to cross a line of 4m at normal speed.

    8 MONTS

  • Body composition

    \- The analysis of body composition will be carried out with the TANITA MC 780-P MA monitor, which provides information on visceral and body fat, skeletal muscle level, BMI and basal metabolism.

    8 MONTHS

  • Respiratoy muscle force

    To measure respiratory muscle force, the maximum respiratory pressures will be evaluated in mouth (PIM/PEM). For them we will use an inspiratory and expiratory mouth pressure monitor maximum, a module of the Datapir touch© spirometer (Sibelmed, Barcelona). The measurement will be performed by a previously trained and experienced physiotherapist, following the protocol established by the Spanish Society of Pulmonology (4-SEPAR).

    8 MONTHS

  • Diaphragmatic ultrasound variables

    The diaphragmatic ultrasound variables examined will be mobility, thickness and fraction of shortening. For this we will use the Esaote MyLab™ Sigma ultrasound machine (Esaote SpA, Genoa, Italy), with double probe (linear and convex).

    8 MONTHS

Secondary Outcomes (1)

  • Health results

    8 MONTHS

Study Arms (2)

Wheelchair

The inclusion criteria to participate in the study are being in a wheelchair, preserved cognitive status and having sufficient ability to Oral occlusion for carrying out respiratory tests. The exclusion criteria are following: presence of respiratory diseases or in treatment of respiratory diseases, serious orthopedic diseases that interfere with measurements and those with a diagnosis of dementia. In addition, those who present any contraindication for carrying out the procedure will be excluded. of the respiratory pressure measurement tests, as established in the SEPAR guidelines. The objectives of the study and the methodology to be used will be explained to all participants. An information sheet will be provided and the informed consent sheet will be given to them.

wanderers

The inclusion criteria to participate in the study are to have functional ambulation, preserved cognitive status and have sufficient ability to Oral occlusion for carrying out respiratory tests. The exclusion criteria are following: presence of respiratory diseases or in treatment of respiratory diseases, serious orthopedic diseases that interfere with measurements and those with a diagnosis of dementia. In addition, those who present any contraindication for carrying out the procedure will be excluded. of the respiratory pressure measurement tests, as established in the SEPAR guidelines. The objectives of the study and the methodology to be used will be explained to all participants. An information sheet will be provided and the informed consent sheet will be given to them.

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Institutionalized elderly diagnosed with respiratory sarcopenia

You may qualify if:

  • To have functional ambulation and/or wheelchair.
  • preserved cognitive status.
  • have sufficient ability to Oral occlusion for carrying out respiratory tests.

You may not qualify if:

  • presence of respiratory diseases or in treatment of respiratory diseases.
  • serious orthopedic diseases that interfere with measurements and those with a diagnosis of dementia.
  • those who present any contraindication for carrying out the procedure will be excluded.
  • of the respiratory pressure measurement tests, as established in the SEPAR guidelines.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Residence of the elderly

Murcia, Spain

Location

MeSH Terms

Conditions

SarcopeniaRespiratory Insufficiency

Condition Hierarchy (Ancestors)

Muscular AtrophyNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesAtrophyPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsSigns and SymptomsRespiration DisordersRespiratory Tract Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Year
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Investigator

Study Record Dates

First Submitted

October 30, 2023

First Posted

November 14, 2023

Study Start

May 1, 2023

Primary Completion

December 31, 2023

Study Completion

July 31, 2025

Last Updated

August 20, 2025

Record last verified: 2024-01

Data Sharing

IPD Sharing
Will not share

Locations